A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect. Visual field testing showed no significant defect in both eyes. Systemic investigations revealed no abnormality. The patient was injected with bevacizumab intravitreally with the diagnosis of diabetic papillopathy (DP). Three weeks later, the vision increased to 7/10 in the right eye and optic disc edema disappeared. Intravitreal injection of bevacizumab effectively treated DP.
Get full access to this article
View all access options for this article.
References
1.
BayraktarZ ., AlacaliN., and BayraktarS. Diabetic papillopathy in type II diabetic patients. Retina. 22:752–758, 2002.
2.
ErdurmanF.C ., DurukanA.H ., MumcuogluT ., et al. Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis. Ocul. Immunol. Inflamm., 17:56–58, 2009.
3.
FingerP.T. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am. J. Ophthalmol., 143:335–338, 2007.
4.
BennettJ.L ., ThomasS ., OlsonJ.L ., et al. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J. Neuroophthalmol. 27:238–240, 2007.
5.
ÇakırM ., ÇekiçO ., BozkurtE ., et al. Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis. Ocul. Immunol. Inflamm., 17:221–223, 2009.
6.
Al-HaddadC.E ., JurdiF.A., and BashshurZ.F. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am. J. Ophthalmol. 137:1151–1153, 2004.
7.
MansourA.M ., El-DairiM.A ., ShehabM.A ., et al. Periocular corticosteroids in diabetic papillopathy. Eye (Lond). 19:45–51, 2005.
